Article, 2024

Abstract 3100: Interactive analysis of drug testing data for functional precision oncology with Breeze 2.0

Cancer Research, ISSN 1538-7445, 0008-5472, Volume 84, 6_Supplement, Page 3100, 10.1158/1538-7445.am2024-3100

Contributors

Potdar, Swapnil 0000-0002-2778-6918 [1] Ianevski, Filipp [1] Ianevski, Aleksandr 0000-0002-7780-482X [1] Tanoli, Ziaurrehman 0000-0003-2435-9862 [1] Wennerberg, Krister 0000-0002-1352-4220 [2] Seashore-Ludlow, Brinton A 0000-0001-8658-5967 [3] Kallioniemi, Olli [3] Östling, Päivi 0000-0001-5501-466X [3] Aittokallio, Tero A 0000-0002-0886-9769 [1] Saarela, Jani [1]

Affiliations

  1. [1] University of Helsinki
  2. [NORA names: Finland; Europe, EU; Nordic; OECD];
  3. [2] University of Copenhagen
  4. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  5. [3] Karolinska Institutet
  6. [NORA names: Sweden; Europe, EU; Nordic; OECD]

Abstract

Abstract High throughput screening (HTS) is used to screen large numbers of small molecules in cell-based assays to predicting their potential therapeutic response and when applying approved drug libraries using HTS it becomes drug repurposing. The Drug Sensitivity and Resistance Testing (DSRT) platform established at FIMM has been extensively used in testing panels of approved and investigational drugs on cells, both conventional cell lines and primary cell models derived from cancer patient samples. The results help in deepen our understanding of drug efficacy in individual patients and across specific disease to guide future patient stratification. Breeze 2.0 is an open access, web-based platform for interactive analysis of drug screening data in real time. Breeze accepts raw data in a simple tabular format and generates detailed quality control metrics, plots, dose-response curve fits, drug response quantification in form of IC50/EC50/AUC and Drug Sensitivity Scores (DSS). Besides tabular results, Breeze generates interactive, informative, and intuitive visualizations, such as plate heatmaps, scatterplots, barplots, clustered heatmaps, circular plots, for further analysis. Based on manually-curated published datasets available through Breeze 2.0, users can instantly compare their drug response patterns with the existing DSRT profiles from patient samples, as well as cell lines. Importantly, Breeze 2.0 has integrated curated reference DSRT data tested on bone marrow samples from healthy control individuals, which plays a crucial role in understanding cancer-selective drug response by de-prioritizing generally toxic compounds. The end-users can select multiple healthy controls or relevant patient/cell line samples and choose the drugs of interest to visualize the overlaid dose responses, as well as response quantification metrics. Breeze 2.0 is built in R, PHP, MySQL and is freely accessible at https://breeze.fimm.fi/v2 Citation Format: Swapnil Potdar, Filipp Ianevski, Aleksandr Ianevski, Ziaurrehman Tanoli, Krister Wennerberg, Brinton Seashore-Ludlow, Olli Kallioniemi, Päivi Östling, Tero Aittokallio, Jani Saarela. Interactive analysis of drug testing data for functional precision oncology with Breeze 2.0 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3100.

Keywords

Abstract, Abstract High-throughput screening, American, American Association for Cancer Research annual meetings, Annual Meeting, Ca, DSRT, Diego, FIMM, MySQL, PHP, San, San Diego, analysis, assay, barplots, bone, bone marrow samples, breeze, cancer, cancer patient samples, cell lines, cell model, cell-based assays, cells, circular plots, clustering heatmap, compounds, control, control individuals, conventional cell lines, curve fitting, data, disease, dose response, dose-response curve fitting, drug, drug efficacy, drug library, drug repurposing, drug response, drug response patterns, drug screening data, drug sensitivity, drug sensitivity scores, drug testing data, efficacy, end-users, fitness, formation, functional precision oncology, healthy control individuals, healthy controls, heatmap, high-throughput screening, individual patients, individuals, interaction analysis, intuitive visualization, investigational drugs, large numbers, library, line samples, lines, manually-curated, marrow samples, meeting, metrics, model, molecules, number, oncology, panel, patient samples, patient stratification, patients, patterns, plate, platform, plots, potential therapeutic responses, precision oncology, primary cell model, proceedings, profile, quantification, quantification metrics, real time, repurposing, resistance, resistance testing, response, response patterns, response quantification, results, samples, scatterplots, scores, screening, screening data, screening large numbers, sensitivity, sensitivity scores, small molecules, stratification, tabular format, tabular results, test, test data, test panel, therapeutic response, throughput screening, time, toxic compounds, users, visualization, web-based platform

Data Provider: Digital Science